ACS Publications. Most Trusted. Most Cited. Most Read

OR SEARCH CITATIONS

My Activity
Publications
CONTENT TYPES

Figure 1Loading Img
Download Hi-Res ImageDownload to MS-PowerPointCite This:J. Med. Chem. 2010, 53, 15, 5400-5421
RETURN TO ISSUEPREVArticleNEXT

Identification of Orally Available Naphthyridine Protein Kinase D Inhibitors

View Author Information
† Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139
‡ Novartis Institutes for BioMedical Research, Basel, Switzerland
§ Gilead Colorado, Inc., 3333 Walnut Street, Boulder, Colorado 80301
*To whom correspondence should be addressed. Phone: 617-871-7606. Fax: 617-871-7045. E-mail: [email protected]
Cite this: J. Med. Chem. 2010, 53, 15, 5400–5421
Publication Date (Web):July 14, 2010
https://doi.org/10.1021/jm100075z
Copyright © 2010 American Chemical Society
Request reuse permissions

    Article Views

    3197

    Altmetric

    -

    Citations

    44
    LEARN ABOUT THESE METRICS
    Read OnlinePDF (4 MB)
    Get e-Alerts
    Supporting Info (1)»
    SUBJECTS:

    Abstract

    Abstract Image

    A novel 2,6-naphthyridine was identified by high throughput screen (HTS) as a dual protein kinase C/D (PKC/PKD) inhibitor. PKD inhibition in the heart was proposed as a potential antihypertrophic mechanism with application as a heart failure therapy. As PKC was previously identified as the immediate upstream activator of PKD, PKD vs PKC selectivity was essential to understand the effect of PKD inhibition in models of cardiac hypertrophy and heart failure. The present study describes the modification of the HTS hit to a series of prototype pan-PKD inhibitors with routine 1000-fold PKD vs PKC selectivity. Example compounds inhibited PKD activity in vitro, in cells, and in vivo following oral administration. Their effects on heart morphology and function are discussed herein.

    Supporting Information

    ARTICLE SECTIONS
    Jump To

    Figures S1 and S2 showing the PK iv and po curves for 13c and 13y; Table T1 listing percent activity remaining for kinases. This material is available free of charge via the Internet at http://pubs.acs.org.

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    This article is cited by 44 publications.

    1. Qiming Jane Wang, Peter Wipf. Small Molecule Inhibitors of Protein Kinase D: Early Development, Current Approaches, and Future Directions. Journal of Medicinal Chemistry 2023, 66 (1) , 122-139. https://doi.org/10.1021/acs.jmedchem.2c01599
    2. Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, Chenzhong Liao. Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. Journal of Medicinal Chemistry 2021, 64 (3) , 1283-1345. https://doi.org/10.1021/acs.jmedchem.0c01511
    3. Wei Fan, Qin Ye, Hai-Wei Xu, Bo Jiang, Shu-Liang Wang, and Shu-Jiang Tu . Novel Double [3 + 2 + 1] Heteroannulation for Forming Unprecedented Dipyrazolo-Fused 2,6-Naphthyridines. Organic Letters 2013, 15 (9) , 2258-2261. https://doi.org/10.1021/ol4008266
    4. Karla Bravo-Altamirano, Kara M. George, Marie-Céline Frantz, Courtney R. LaValle, Manuj Tandon, Stephanie Leimgruber, Elizabeth R. Sharlow, John S. Lazo, Q. Jane Wang, and Peter Wipf . Synthesis and Structure−Activity Relationships of Benzothienothiazepinone Inhibitors of Protein Kinase D. ACS Medicinal Chemistry Letters 2011, 2 (2) , 154-159. https://doi.org/10.1021/ml100230n
    5. Erik L. Meredith, Kimberly Beattie, Robin Burgis, Michael Capparelli, Joseph Chapo, Lucian DiPietro, Gabriel Gamber, Istvan Enyedy, David B. Hood, Vinayak Hosagrahara, Charles Jewell, Keith A. Koch, Wendy Lee, Douglas D. Lemon, Timothy A. McKinsey, Karl Miranda, Nikos Pagratis, Dillon Phan, Craig Plato, Chang Rao, Olga Rozhitskaya, Nicolas Soldermann, Clayton Springer, Maurice van Eis, Richard B. Vega, Wanlin Yan, Qingming Zhu and Lauren G. Monovich . Identification of Potent and Selective Amidobipyridyl Inhibitors of Protein Kinase D. Journal of Medicinal Chemistry 2010, 53 (15) , 5422-5438. https://doi.org/10.1021/jm100076w
    6. Wei Fan. Bicyclization reactions of 1-aryl pyrazol-5-amines with 2,2-dihydroxyindene-1,3-dione: Selective synthesis of 2,6-naphthyridines and pyrrolizines. Tetrahedron 2023, 137 , 133378. https://doi.org/10.1016/j.tet.2023.133378
    7. Anna Wójcicka. Synthesis and Biological Activity of 2,6-Naphthyridine Derivatives: A Mini Review. Current Organic Chemistry 2023, 27 (8) , 648-660. https://doi.org/10.2174/1385272827666230519165336
    8. Julie Bossuyt, Johanna M. Borst, Marie Verberckmoes, Logan R. J. Bailey, Donald M. Bers, Bence Hegyi. Protein Kinase D1 Regulates Cardiac Hypertrophy, Potassium Channel Remodeling, and Arrhythmias in Heart Failure. Journal of the American Heart Association 2022, 11 (19) https://doi.org/10.1161/JAHA.122.027573
    9. Fiona Scott, Angela M. Fala, Jessica E. Takarada, Mihaela P. Ficu, Lewis E. Pennicott, Tristan D. Reuillon, Rafael M. Couñago, Katlin B. Massirer, Jonathan M. Elkins, Simon E. Ward. Development of dihydropyrrolopyridinone-based PKN2/PRK2 chemical tools to enable drug discovery. Bioorganic & Medicinal Chemistry Letters 2022, 60 , 128588. https://doi.org/10.1016/j.bmcl.2022.128588
    10. Susan F. Steinberg. Decoding the Cardiac Actions of Protein Kinase D Isoforms. Molecular Pharmacology 2021, 100 (6) , 558-567. https://doi.org/10.1124/molpharm.121.000341
    11. Philippe Gilles, Lauren Voets, Johan Van Lint, Wim M. De Borggraeve. Developments in the Discovery and Design of Protein Kinase D Inhibitors. ChemMedChem 2021, 16 (14) , 2158-2171. https://doi.org/10.1002/cmdc.202100110
    12. Die Lv, Hongli Chen, Yun Feng, Bomiao Cui, Yingzhu Kang, Ping Zhang, Min Luo, Jiao Chen. Small-Molecule Inhibitor Targeting Protein Kinase D: A Potential Therapeutic Strategy. Frontiers in Oncology 2021, 11 https://doi.org/10.3389/fonc.2021.680221
    13. Xuejing Zhang, Jaclyn Connelly, Yapeng Chao, Qiming Jane Wang. Multifaceted Functions of Protein Kinase D in Pathological Processes and Human Diseases. Biomolecules 2021, 11 (3) , 483. https://doi.org/10.3390/biom11030483
    14. Ming-Shu Wang, Yi Gong, Zhi-Cheng Yu, Yan-Guang Tian, Lin-Sheng Zhuo, Wei Huang, Neng-Fang She. Grignard Reagent Utilization Enables a Practical and Scalable Construction of 3-Substituted 5-Chloro-1,6-naphthyridin-4-one Derivatives. Molecules 2020, 25 (23) , 5667. https://doi.org/10.3390/molecules25235667
    15. Philippe Gilles, Rudra S. Kashyap, Maria João Freitas, Sam Ceusters, Koen Van Asch, Anke Janssens, Steven De Jonghe, Leentje Persoons, Mathias Cobbaut, Dirk Daelemans, Johan Van Lint, Arnout R.D. Voet, Wim M. De Borggraeve. Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyrimidine-based protein kinase D inhibitors. European Journal of Medicinal Chemistry 2020, 205 , 112638. https://doi.org/10.1016/j.ejmech.2020.112638
    16. Hye Jin Jeong, Sein Min, Keunhong Jeong. Analysis of 1-aminoisoquinoline using the signal amplification by reversible exchange hyperpolarization technique. The Analyst 2020, 145 (20) , 6478-6484. https://doi.org/10.1039/D0AN00967A
    17. Ya Li, Zimu Su, Haijun Hao, Junpeng Zhuang. Photoinduced direct hydration of dipyridylacetylenes in acidic aqueous solution. Chemical Communications 2020, 56 (55) , 7669-7672. https://doi.org/10.1039/D0CC01351J
    18. Yan Liu, Hang Song, Shiyi Yu, Kuo‐Hsiang Huang, Xinxing Ma, Yehui Zhou, Shuang Yu, Jingzhong Zhang, Liming Chen. Protein Kinase D3 promotes the cell proliferation by activating the ERK1/c‐MYC axis in breast cancer. Journal of Cellular and Molecular Medicine 2020, 24 (3) , 2135-2144. https://doi.org/10.1111/jcmm.14772
    19. Ilige Youssef, Jean-Marc Ricort. Deciphering the Role of Protein Kinase D1 (PKD1) in Cellular Proliferation. Molecular Cancer Research 2019, 17 (10) , 1961-1974. https://doi.org/10.1158/1541-7786.MCR-19-0125
    20. Raju Dash, Md. Arifuzzaman, Sarmistha Mitra, Md. Abdul Hannan, Nurul Absar, S.M. Zahid Hosen. Unveiling the Structural Insights into the Selective Inhibition of Protein Kinase D1. Current Pharmaceutical Design 2019, 25 (10) , 1059-1074. https://doi.org/10.2174/1381612825666190527095510
    21. M. Bilge. A Dft Investigation of the Interaction of B- And Al-Doped C60 Fullerenes with Cyclopropylpipezarine. Journal of Structural Chemistry 2018, 59 (6) , 1271-1275. https://doi.org/10.1134/S0022476618060045
    22. Ninel Azoitei, Mathias Cobbaut, Alexander Becher, Johan Van Lint, Thomas Seufferlein. Protein kinase D2: a versatile player in cancer biology. Oncogene 2018, 37 (10) , 1263-1278. https://doi.org/10.1038/s41388-017-0052-8
    23. Nalini, Navriti Chadha, Malkeet Singh Bahia, Maninder Kaur, Renu Bahadur, Om Silakari. Computational design of new protein kinase D 1 (PKD1) inhibitors: homology-based active site prediction, energy-optimized pharmacophore, docking and database screening. Molecular Diversity 2018, 22 (1) , 47-56. https://doi.org/10.1007/s11030-017-9785-0
    24. Adhiraj Roy, Jing Ye, Fan Deng, Qiming Jane Wang. Protein kinase D signaling in cancer: A friend or foe?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2017, 1868 (1) , 283-294. https://doi.org/10.1016/j.bbcan.2017.05.008
    25. Klaas Verschueren, Mathias Cobbaut, Joachim Demaerel, Lina Saadah, Arnout R. D. Voet, Johan Van Lint, Wim M. De Borggraeve. Discovery of a potent protein kinase D inhibitor: insights in the binding mode of pyrazolo[3,4-d]pyrimidine analogues. MedChemComm 2017, 8 (3) , 640-646. https://doi.org/10.1039/C6MD00675B
    26. Zhuang Xiong, Jian Wang, Yanbo Wang, Shuang Luo, Qiang Zhu. Palladium-catalyzed C(sp 2 )–H aminoimidoylation of isocyano-containing arenes: synthesis of amino substituted N-heterocycles. Organic Chemistry Frontiers 2017, 4 (9) , 1768-1771. https://doi.org/10.1039/C7QO00368D
    27. Sibaji Nandi, Mullah Muhaiminul Islam, Mithu Saha, Sivaprasad Mitra, Snehadrinarayan Khatua, Amarta Kumar Pal. Regioselective synthesis of functionalized [1,6]-naphthyridines by KF/basic alumina as a recyclable catalyst and a brief study of their photophysical properties. Synthetic Communications 2016, 46 (17) , 1461-1476. https://doi.org/10.1080/00397911.2016.1209778
    28. Weston W. Blakeslee, Philip D. Tatman, Timothy A. McKinsey. Epigenetic and Nongenomic Roles for Histone Deacetylases in Heart Failure. 2016, 209-229. https://doi.org/10.1007/978-3-319-41457-7_9
    29. Nisha Durand, Sahra Borges, Peter Storz. Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer. Cellular and Molecular Life Sciences 2015, 72 (22) , 4369-4382. https://doi.org/10.1007/s00018-015-2011-2
    30. Douglas D. Lemon, Brooke C. Harrison, Todd R. Horn, Matthew S. Stratton, Bradley S. Ferguson, Michael F. Wempe, Timothy A. McKinsey. Promiscuous actions of small molecule inhibitors of the protein kinase D‐class IIa HDAC axis in striated muscle. FEBS Letters 2015, 589 (10) , 1080-1088. https://doi.org/10.1016/j.febslet.2015.03.017
    31. Lorenz H. Lehmann, Barbara C. Worst, David A. Stanmore, Johannes Backs. Histone deacetylase signaling in cardioprotection. Cellular and Molecular Life Sciences 2014, 71 (9) , 1673-1690. https://doi.org/10.1007/s00018-013-1516-9
    32. Nicky J. Willis, James M. Smith. An operationally simple, palladium catalysed dehydrogenative cross-coupling reaction of pyridine N-oxides and thiazoles “on water”. RSC Advances 2014, 4 (22) , 11059. https://doi.org/10.1039/c3ra44411b
    33. Manuj Tandon, James Johnson, Zhihong Li, Shuping Xu, Peter Wipf, Qiming Jane Wang, . New Pyrazolopyrimidine Inhibitors of Protein Kinase D as Potent Anticancer Agents for Prostate Cancer Cells. PLoS ONE 2013, 8 (9) , e75601. https://doi.org/10.1371/journal.pone.0075601
    34. Sahra Borges, Peter Storz. Protein kinase D isoforms: new targets for therapy in invasive breast cancers?. Expert Review of Anticancer Therapy 2013, 13 (8) , 895-898. https://doi.org/10.1586/14737140.2013.816460
    35. Robert S. Haworth, Konstantina Stathopoulou, Alexandra J. Candasamy, Metin Avkiran. Neurohormonal Regulation of Cardiac Histone Deacetylase 5 Nuclear Localization by Phosphorylation-Dependent and Phosphorylation-Independent Mechanisms. Circulation Research 2012, 110 (12) , 1585-1595. https://doi.org/10.1161/CIRCRESAHA.111.263665
    36. Yong-Shan Zhao, Kun Wang, Hong Zeng, Hong-Xing Zhang, Jing-Hai Zhang. A comparative analysis of binding sites between human PKD1 and PKC1 based on homology modelling, molecular dynamics simulation and docking studies. Molecular Simulation 2012, 38 (4) , 309-314. https://doi.org/10.1080/08927022.2011.631010
    37. Maurice J. van Eis, Jean-Pierre Evenou, Philipp Floersheim, Christoph Gaul, Sandra W. Cowan-Jacob, Lauren Monovich, Gabriele Rummel, Walter Schuler, Wilhelm Stark, Andre Strauss, Anette von Matt, Eric Vangrevelinghe, Juergen Wagner, Nicolas Soldermann. 2,6-Naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes. Bioorganic & Medicinal Chemistry Letters 2011, 21 (24) , 7367-7372. https://doi.org/10.1016/j.bmcl.2011.10.025
    38. Elizabeth R. Sharlow, Gabriela Mustata Wilson, David Close, Stephanie Leimgruber, Manuj Tandon, Robyn B. Reed, Tong Ying Shun, Q. Jane Wang, Peter Wipf, John S. Lazo, . Discovery of Diverse Small Molecule Chemotypes with Cell-Based PKD1 Inhibitory Activity. PLoS ONE 2011, 6 (10) , e25134. https://doi.org/10.1371/journal.pone.0025134
    39. Julie Bossuyt, Chia-Wei Chang, Kathryn Helmstadter, Maya T. Kunkel, Alexandra C. Newton, Kenneth S. Campbell, Jody L. Martin, Sven Bossuyt, Seth L. Robia, Donald M. Bers. Spatiotemporally Distinct Protein Kinase D Activation in Adult Cardiomyocytes in Response to Phenylephrine and Endothelin. Journal of Biological Chemistry 2011, 286 (38) , 33390-33400. https://doi.org/10.1074/jbc.M111.246447
    40. Shengqing Ye, Huanhuan Wang, Jie Wu. An expeditious approach to 1-aminoisoquinolines via an unexpected reaction of 2-alkynylbenzaldoxime, carbodiimide, with bromine. Tetrahedron 2011, 67 (25) , 4628-4632. https://doi.org/10.1016/j.tet.2011.04.063
    41. Kara M. George, Marie-Céline Frantz, Karla Bravo-Altamirano, Courtney R. LaValle, Manuj Tandon, Stephanie Leimgruber, Elizabeth R. Sharlow, John S. Lazo, Q. Jane Wang, Peter Wipf. Design, Synthesis, and Biological Evaluation of PKD Inhibitors. Pharmaceutics 2011, 3 (2) , 186-228. https://doi.org/10.3390/pharmaceutics3020186
    42. Gabriel G. Gamber, Erik Meredith, Qingming Zhu, Wanlin Yan, Chang Rao, Michael Capparelli, Robin Burgis, Istvan Enyedy, Ji-Hu Zhang, Nicolas Soldermann, Kimberley Beattie, Olga Rozhitskaya, Keith A. Koch, Nikos Pagratis, Vinayak Hosagrahara, Richard B. Vega, Timothy A. McKinsey, Lauren Monovich. 3,5-Diarylazoles as novel and selective inhibitors of protein kinase D. Bioorganic & Medicinal Chemistry Letters 2011, 21 (5) , 1447-1451. https://doi.org/10.1016/j.bmcl.2011.01.014
    43. Timothy A. McKinsey. The Biology and Therapeutic Implications of HDACs in the Heart. 2011, 57-78. https://doi.org/10.1007/978-3-642-21631-2_4
    44. Danqing Zheng, Zhiyuan Chen, Jianping Liu, Jie Wu. An efficient route to 1-aminoisoquinolines via AgOTf-catalyzed reaction of 2-alkynylbenzaldoxime with amine. Organic & Biomolecular Chemistry 2011, 9 (13) , 4763. https://doi.org/10.1039/c1ob05582h
    Download PDF

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    MENDELEY PAIRING EXPIRED
    Your Mendeley pairing has expired. Please reconnect